• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."

    --Gandhi

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Vote!

FDA Approves Aristada for the Treatment of Schizophrenia

The Food and Drug Administration on Monday approved Aristada (aripiprazole lauroxil), a long-acting injectable antipsychotic, for the treatment of schizophrenia. The medication requires administration by a health care professional every four to six weeks. The approval of Aristada was based, in part, on the results of a 12-week clinical trial of 623 participants with schizophrenia who were experiencing an acute exacerbation. Participants were randomly assigned to receive a gluteal intramuscular injection of aripiprazole lauroxil (441 mg), aripiprazole lauroxil (882 mg), or matching placebo once monthly for 12 weeks. Patients in...

read more...

Share |

Published By: Psychiatric News - Wednesday, 7 October, 2015

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.